Tuesday, March 6, 2012

Xoma seeks $39.2M from sale of stock, warrants

Antibody drug developer Xoma Corp. would raise $39.2 million by selling nearly 29.7 million shares plus warrants.
Berkeley-based Xoma (NASDAQ: XOMA) on Tuesday priced the common stock and warrants to buy one-half of a share of common stock for each share purchased at $1.32.

No comments:

Post a Comment

Post a Comment